The Supreme Court today unanimously struck down patents on BRCA1 and BRCA2
When Angelina Jolie announced last month that she decided to get a prophylactic double mastectomy, she based her decision on the presence of the BRCA1 gene in her body—a gene that was detected via a costly medical test.
The Supreme Court today unanimously struck down patents on BRCA1 and BRCA2—two genes linked to hereditary forms of breast and ovarian cancer—when the genes occur in the body. Myriad did not create or alter any of the genetic information of the BCRA1 and BRCA2 genes, and thus does not satisfy patenting requirements, according to the decision. “Myriad discovered the precise location and sequence of what are now known as the BRCA1 and BRCA2 genes,” Justice Clarence Thomas wrote for the court.
This ruling could lead to cheaper tests for individuals who may be at increased risk of developing cancer. If Myriad Genetics were allowed to hold exclusive patents on these genes, the company would have maintained sole rights to create medical tests that indicate whether an individual has mutations that would lead to elevated risk of developing these cancers.
The ruling should also affect the medical research community. Because the genes were patented, any researcher who found a new way to isolate the genes would not have been able to use it, since Myriad held patents on the genes themselves. The court’s decision removes that restriction.
On average, women have a 12 to 13 percent risk of developing breast cancer over their lifetimes, but that risk spikes with the presence of mutations in the BRCA1 andBRCA2 genes—jumping to between 50 and 80 percent for breast cancer and 20 and 50 percent for ovarian cancer, the decision notes.
Myriad had identified the exact location of the BRCA1 and BRCA2 genes; it had not discovered that heredity plays a role in establishing risk of breast and ovarian cancer. “Myriad did not create anything,” Thomas wrote. “To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention.” “I’m just incredibly relieved,” says Lisbeth Ceriani, a breast cancer survivor and original plaintiff who struggled to afford Myriad’s test.
The Latest Bing News on:
Gene patents
- Mustang Bio to Participate in Three March 2021 Virtual Investor Conferenceson March 4, 2021 at 5:10 am
Stock quotes by finanzen.net WORCESTER, Mass., March 04, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating ...
- Syros Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestoneson March 4, 2021 at 4:30 am
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today reported financial results for the quarter and full year ended December 31, ...
- GeoVax Expands and Strengthens Intellectual Property Portfolioon March 3, 2021 at 10:57 pm
Atlanta, GA, March 04, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and ...
- Broadridge's LTX® Granted Patent for Innovative RFX® Protocol to Significantly Improve Corporate Bond Tradingon March 3, 2021 at 4:26 am
Empowering broker-dealers and institutional investors to better connect and trade corporate bonds digitally, Broadridge Financial Solutions, Inc. , a global Fintech leader, today announced that the U.
- Humanigen Expands its anti-GM-CSF Patent Portfolioon March 2, 2021 at 9:33 pm
(Nasdaq: HGEN) (“Humanigen”) a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab™, ...
- CRISPR rivals put patents aside to help in fight against Covid-19on March 2, 2021 at 8:40 pm
When Feng Zhang and Jennifer Doudna began using CRISPR to detect Covid-19 infection, their discoveries were open for all and without patents.
- A 'love story': WuXi AppTec wraps UK-based CRO into its cell and gene therapy uniton March 2, 2021 at 4:31 am
When WuXi AppTec, one of China’s largest contract research organizations, started working with UK-based Oxgene about a year ago, it was “love at first sight,” CEO David Chang jokes. Oxgene, a roughly ...
- Applied DNA Granted U.S. Patent Covering Methods of Utilizing DNA Tagged Submicron Particles for Authenticationon February 25, 2021 at 6:00 am
Applied DNA Sciences, Inc. a leader in Polymerase Chain Reaction- based DNA manufacturing, announced today that it has received United States Patent No. 10,920,274 entitled“ Nucleic Acid Coated ...
- Coronavirus live news: African Union calls on drugmakers to drop patents to accelerate vaccine rollouton February 25, 2021 at 5:02 am
Drugmakers urged to waive intellectual property rights; Ukraine registered 8,147 cases on Wednesday ...
- Patenting Software-Related Inventions Is Getting Easieron February 23, 2021 at 2:07 pm
Some software-related patent claims that might have been rejected by examiners in the past might now be found eligible in light of the U.S. Patent and Trademark Office's 2019 eligibility guidance and ...
The Latest Google Headlines on:
Gene patents
The Latest Bing News on:
Patent trolls
- Frivolous Patent Litigation Threatens The Technology Revolutionon March 4, 2021 at 6:47 am
Frivolous litigation that uses the court system as a negotiation tactic threatens to diminish the benefits from deploying 5G technologies. Congress can help alleviate this problem by reforming ITC ...
- Intel told to pay $2.2 billion in patent infringement lawsuiton March 3, 2021 at 5:47 am
As reported by Bloomberg Law, a jury in Waco, Texas, ruled that Intel must pay $1.5 billion for infringement of one patent and $675 million for ...
- Intel Ordered to Pay $2.2 Billion in Patent Infringement Caseon March 2, 2021 at 11:30 pm
Intel has been hit with a massive $2.2B patent infringement judgment. The company has pledged to appeal the ruling.
- Intel ordered to pay $2.18 billion for patent infringementon March 2, 2021 at 5:15 pm
Computer chipmaker Intel Corp. suffered a major blow today after losing a high-profile patent infringement trial and being ordered to pay $2.18 billion in compensation. Intel had denied infringing on ...
- Menu Patent Biz Fights Domino's Fee Win, Says It's No Trollon March 1, 2021 at 5:07 pm
Ameranth Inc. has argued that a California federal judge should reconsider granting Domino's bid to collect millions in attorney fees after Ameranth brought a case the judge had called "especially ...
- Justices Hint That They Might Fix PTO Appointment Clause Problemon March 1, 2021 at 12:21 pm
Several justices suggested that severing a minor provision in the America Invents Act would be preferable to the Federal Circuit's approach of removing administrative patent judges' civil service ...
- Almost 200 patent infringement claims against Apple may have been rejected illegallyon February 28, 2021 at 10:30 pm
Almost 200 patent infringement claims against Apple may have been rejected illegally, says a new report today. The US Supreme Court ...
- Australian patent troll goes after Apple for Face ID and Touch IDon February 24, 2021 at 4:57 am
An Australian patent troll is claiming that Apple's Face ID and Touch ID systems – especially when used with Apple Pay – infringe on ...
- Australia's CPC Patent Technologies Claims that Apple's iPhone using Face or Touch ID Infringes three of their Acquired Patentson February 24, 2021 at 2:54 am
which makes CPC Patent Technologies a Patent Troll or nonpracticing entity or nonproducing entity (NPE). For more details, read the Plaintiff's full complaint filed with the court in the SCRIBD ...
- What Is a Patent Troll?on February 23, 2021 at 11:42 pm
The investing landscape is always changing, and over the years, the universe of investment vehicles only tends to get larger and more complex. Whereas decades ago Wall Street was largely just a matter ...
